Czechia· CZ-0281653

COMIRNATY JN.1

A covid-19, rna-based vaccine product containing bretovameran, registered in Czechia by BioNTech Manufacturing GmbH, Mainz. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedCOMIRNATY JN.1ATCJ07BN01REGISTER NO.CZ-0281653PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
BRETOVAMERAN
Manufacturer
BioNTech Manufacturing GmbH, Mainz
Country
Czechia (CZ)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Covid-19, rna-based vaccine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All covid-19, rna-based vaccine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Comirnaty Jn.1
  • Liechtenstein · Comirnaty Jn.1
  • Norway · Comirnaty Jn.1

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b01da138-7b4a-4bba-8c21-eb0332f47472
GET /v1/drugs/b01da138-7b4a-4bba-8c21-eb0332f47472?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ DIS",
  "source": "sukl",
  "strength": "10MCG/DÁV",
  "pack_size": "10X0,48ML",
  "substance": "BRETOVAMERAN",
  "cz_kod_sukl": "0281653",
  "product_type": "IM/BT",
  "substance_codes": "3923",
  "registration_state": "R",
  "registration_number": "EU/1/20/1528/032"
}

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.